Prof. Torben Plesner, MD, is a world-renowned myeloma expert and currently practices hematology at Vejle Hospital in Denmark, and is a Professor at the University of Southern Denmark, Odense, Denmark.

Prof. Plesner was involved in the earliest work on daratumumab, a promising monoclonal antibody for the treatment of multiple myeloma and has published in several peer-reviewed journals.